Poster accepted for ISCTM in February
Our Alliance group is proud to announce that one of our sites, Hassman Research Institute (HRI), was recently accepted to present their empirical research poster at the International Society for CNS Clinical Trials and Methodology (ISCTM) Conference on Wednesday, 21 February 2018, 6:00 – 7:30 pm EST. If you are attending ISCTM in 2018, please stop by their poster as they are always eager to share their results and answer any questions. Their poster is entitled: “Can Subjects with Major Depression Learn About Key Placebo Response Factors? The Effect of an Educational Placebo Response Video”.
All of our Alliance sites are heavily engaged in reducing the placebo effect impacting CNS clinical trials, and HRI is no exception. The Science Division at HRI conducts numerous empirical investigations focusing on ways to minimize the placebo effect. The poster the team is presenting at ISCTM illustrates that their Placebo Control Response Video, seen by clinical trial subjects, significantly helps participants learn about the four key factors cited in the placebo literature as causing placebo response (lack of subject understanding of the placebo, subject expectations of benefit, subject misconception of expected interactions with research site staff, and subject uncertainty of his/her role in the trial), as compared to subjects in the control group of their study who are not exposed to this brief (8-minute) video.
The Alliance group is very pleased to share this research with you and we hope to see you at ISCTM. If you would like to meet the HRI team members as well as the leaders of our other sites at ISCTM, please call Bobbie Theodore at 916-939-6696.